← Eichor
Condition: Oxaliplatin Induced Peripheral Neuropathy In Cancer Patients Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oxaliplatin Induced Peripheral Neuropathy In Cancer Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients
NA · 5 location(s) · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT05850130
Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT07427537
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
EARLY_Phase 1 · 1 location(s) · Fox Chase Cancer Center · NCT07167446
The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy
Phase 3 · 1 location(s) · Tanta University · NCT05624138
The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Can
Phase 1 · 1 location(s) · toqa saad mohammed mohammed · NCT06856447
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.